Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI WINTHROP INDUSTRIE Gentilly FR
02 1TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa Bay IL
01 2Dipotassium clorazepate monohydrate
01 1France
02 1Israel
01 2Valid
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Dipotassium Clorazepate Monohydrate
Certificate Number : CEP 2008-170 - Rev 02
Status : Valid
Issue Date : 2024-03-28
Type : Chemical
Substance Number : 898
Dipotassium Clorazepate Monohydrate
Certificate Number : R1-CEP 2009-386 - Rev 01
Status : Valid
Issue Date : 2020-06-22
Type : Chemical
Substance Number : 898
A Clorazepate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clorazepate, including repackagers and relabelers. The FDA regulates Clorazepate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clorazepate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clorazepate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clorazepate supplier is an individual or a company that provides Clorazepate active pharmaceutical ingredient (API) or Clorazepate finished formulations upon request. The Clorazepate suppliers may include Clorazepate API manufacturers, exporters, distributors and traders.
click here to find a list of Clorazepate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clorazepate CEP of the European Pharmacopoeia monograph is often referred to as a Clorazepate Certificate of Suitability (COS). The purpose of a Clorazepate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clorazepate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clorazepate to their clients by showing that a Clorazepate CEP has been issued for it. The manufacturer submits a Clorazepate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clorazepate CEP holder for the record. Additionally, the data presented in the Clorazepate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clorazepate DMF.
A Clorazepate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clorazepate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clorazepate suppliers with CEP (COS) on PharmaCompass.
We have 2 companies offering Clorazepate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?